Metabolon Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Metabolon Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010931
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metabolon Inc (Metabolon) is a health technology company that develops clinical diagnostic tests for healthcare markets. The company’s products include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a blood test performed for detecting early-stage insulin resistance and for obesity related chronic diseases. Metabolon provides metabolomics services for various applications in the areas of research in discovery biology, pharmaceutical research and development, clinical trials, nutrition and consumer goods, and bioprocessing and cell culture science. The company collaborates with research institutions, pharmaceutical, nutrition, agricultural and consumer goods companies for its research activities. It has operations in the UK and the US. Metabolon is headquartered in Durham, North Carolina, the US.

Metabolon Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metabolon Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolon Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolon Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolon Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Metabolon Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Metabolon Raises USD15 Million in Venture Financing 11
Metabolon Raises USD5 Million in Venture Financing 12
Metabolon Raises US$15 Million In Series E Financing 13
Metabolon Secures US$13 Million In Series D Financing 15
Private Equity 16
Essex Woodlands Management Invests Additional USD15 Million in Metabolon 16
Partnerships 17
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 17
Metabolon Enters into Licensing Agreement with Synlab 18
Muses Labs Partners with Metabolon 19
Metabolon Enters into Co-Development Agreement with Johns Hopkins University and Tufts Medical Center 20
Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 21
Global Genomics Enters Into Agreement With Metabolon For Cardiovascular Disease Biomarkers And Drug Targets 22
Metabolon And Bostwick Lab Enter Into Agreement To Market Prostarix Test 23
Imdea Food Enters Into Agreement With Metabolon To Advance Nutrition-Based Personalized Medicine 24
Metabolon Enters Into Co-Development Agreement With Takeda Pharma 25
Metabolon Enters Into Licensing Agreement With Patia Biopharma For Quantose Prediabetes Test 26
Acquisition 27
Metabolon Acquires Lipomics Technologies, Diagnostics Company 27
Metabolon Inc – Key Competitors 28
Metabolon Inc – Key Employees 29
Metabolon Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 30
Recent Developments 31
Corporate Communications 31
Jan 26, 2017: Metabolon Announces Changes to Executive Leadership Team 31
Other Significant Developments 32
May 03, 2017: Metabolon to Establish Metabolomics Lab in Qatar to Serve Markets in the Middle East 32
Jan 05, 2017: Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Metabolon Inc, Medical Equipment, Key Facts 2
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Metabolon Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolon Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolon Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolon Inc, Deals By Market, 2011 to YTD 2017 8
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Metabolon Raises USD15 Million in Venture Financing 11
Metabolon Raises USD5 Million in Venture Financing 12
Metabolon Raises US$15 Million In Series E Financing 13
Metabolon Secures US$13 Million In Series D Financing 15
Essex Woodlands Management Invests Additional USD15 Million in Metabolon 16
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 17
Metabolon Enters into Licensing Agreement with Synlab 18
Muses Labs Partners with Metabolon 19
Metabolon Enters into Co-Development Agreement with Johns Hopkins University and Tufts Medical Center 20
Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 21
Global Genomics Enters Into Agreement With Metabolon For Cardiovascular Disease Biomarkers And Drug Targets 22
Metabolon And Bostwick Lab Enter Into Agreement To Market Prostarix Test 23
Imdea Food Enters Into Agreement With Metabolon To Advance Nutrition-Based Personalized Medicine 24
Metabolon Enters Into Co-Development Agreement With Takeda Pharma 25
Metabolon Enters Into Licensing Agreement With Patia Biopharma For Quantose Prediabetes Test 26
Metabolon Acquires Lipomics Technologies, Diagnostics Company 27
Metabolon Inc, Key Competitors 28
Metabolon Inc, Key Employees 29
Metabolon Inc, Other Locations 30
Metabolon Inc, Subsidiaries 30
Metabolon Inc, Joint Venture 30

★海外企業調査レポート[Metabolon Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laboratorios Farmaceuticos Rovi SA (ROVI):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products …
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Castle View International Holdings Limited:企業の戦略・SWOT・財務情報
    Castle View International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Castle View International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Pioneer Hi-Bred International Inc:企業のM&A・事業提携・投資動向
    Pioneer Hi-Bred International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pioneer Hi-Bred International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Horizon Discovery Group Plc (HZD):企業の財務・戦略的SWOT分析
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • America Movil, SA DE C.V.:企業の戦略・SWOT・財務情報
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Concho Resources Inc (CXO):石油・ガス:M&Aディール及び事業提携情報
    Summary Concho Resources Inc (Concho) is an oil and gas company that acquires, develops and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in the US. Co …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PriceSmart Inc (PSMT):企業の財務・戦略的SWOT分析
    PriceSmart Inc (PSMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Southwest Gas Holdings, Inc.:企業の戦略・SWOT・財務分析
    Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DermTech Inc-医療機器分野:企業M&A・提携分析
    Summary DermTech Inc (DermTech) is a precision medicine developer that offers molecular tests. The company’s products include adhesive skin sample collection kit and pigmented lesion assay. Its EGIR platform technology is applicable in non-invasive, genomic-based disease detection, theranostics, pha …
  • Habib Insurance Co Ltd (HICL):企業の財務・戦略的SWOT分析
    Habib Insurance Co Ltd (HICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Laredo Petroleum, Inc. (LPI)-石油・ガス分野:企業M&A・提携分析
    Summary Laredo Petroleum, Inc. (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company …
  • Cantargia AB (CANTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • European Medical Contract Manufacturing BV:医療機器:M&Aディール及び事業提携情報
    Summary European Medical Contract Manufacturing BV (EMCM BV), a subsidiary of Leader Biomedical Group, is a developer and manufacturer of sterile medicinal products. The company’s products include bone cements for hip and knee arthroplasty and vertebroplasty procedures; cement restrictors; human bon …
  • Taseko Mines Limited:企業の戦略・SWOT・財務情報
    Taseko Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Taseko Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Grupa Azoty SA (ATT):企業の財務・戦略的SWOT分析
    Grupa Azoty SA (ATT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Entellus Medical Inc (ENTL):企業の財務・戦略的SWOT分析
    Summary Entellus Medical Inc (Entellus Medical) a subsidiary of Stryker Corp, operates as a medical device company that offers invasive products for the treatment of chronic sinusitis. The company’s products include multi sinus dilation system, surgical instruments, sinonasal suction and irrigation …
  • ARC Resources Ltd (ARX):企業の財務・戦略的SWOT分析
    ARC Resources Ltd (ARX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆